Join our mailing list
Get exclusive deals and learn about new products!
Reliable shipping
Flexible returns
Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest.
The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today’s research.
Published by: Springer
Publication Date: 2012-01-05
Format: Paperback
ISBN-13: 9783642249792
DOI: 10.1007/978-3-642-24980-8
Dimensions: 235cm x155cm
Pages: 74